{"id":"https://openalex.org/W1029379792","doi":null,"title":"ACTIONS OF PI3K-DELTA INHIBITOR, IDELALISIB, AND ITS COMBINATION WITH BENDAMUSTINE IN CHRONIC LYMPHOCYTIC LEUKEMIA","display_name":"ACTIONS OF PI3K-DELTA INHIBITOR, IDELALISIB, AND ITS COMBINATION WITH BENDAMUSTINE IN CHRONIC LYMPHOCYTIC LEUKEMIA","publication_year":2015,"publication_date":"2015-01-01","ids":{"openalex":"https://openalex.org/W1029379792","mag":"1029379792"},"language":"en","primary_location":{"id":"pmh:oai:digitalcommons.library.tmc.edu:utgsbs_dissertations-1626","doi":null,"is_oa":true,"landing_page_url":"https://digitalcommons.library.tmc.edu/utgsbs_dissertations/586","pdf_url":"https://digitalcommons.library.tmc.edu/utgsbs_dissertations/586","source":{"id":"https://openalex.org/S4377196655","display_name":"Digital Commons-TMC (Texas Medical Center)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1337852284","host_organization_name":"Texas Medical Center","host_organization_lineage":["https://openalex.org/I1337852284"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Dissertations & Theses (Open Access)","raw_type":"text"},"volume":null,"type":"dissertation","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://digitalcommons.library.tmc.edu/utgsbs_dissertations/586","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066969710","display_name":"Prexy Modi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Prexy Modi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5066969710"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/idelalisib","display_name":"idelalisib","score":0.875},{"id":"https://openalex.org/keywords/bendamustine","display_name":"bendamustine","score":0.9959999918937683},{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.9860000014305115},{"id":"https://openalex.org/keywords/pi3kdelta-inhibitor","display_name":"PI3K\u03b4 inhibitor","score":0.8759999871253967},{"id":"https://openalex.org/keywords/mcl-1","display_name":"Mcl-1","score":0.8759999871253967},{"id":"https://openalex.org/keywords/b-cell-receptor-signaling","display_name":"B cell receptor signaling","score":0.7549999952316284},{"id":"https://openalex.org/keywords/akt-phosphorylation","display_name":"Akt phosphorylation","score":0.8889999985694885},{"id":"https://openalex.org/keywords/dna-damage-response","display_name":"DNA damage response","score":0.7829999923706055},{"id":"https://openalex.org/keywords/gamma-h2ax","display_name":"\u03b3H2AX","score":0.8040000200271606},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.8410000205039978},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6399999856948853},{"id":"https://openalex.org/keywords/synergistic-cytotoxicity","display_name":"synergistic cytotoxicity","score":0.8759999871253967},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.5709999799728394},{"id":"https://openalex.org/keywords/bcl-2-family-proteins","display_name":"Bcl-2 family proteins","score":0.5189999938011169},{"id":"https://openalex.org/keywords/rna-synthesis-inhibition","display_name":"RNA synthesis inhibition","score":0.4099999964237213},{"id":"https://openalex.org/keywords/alkylating-agents","display_name":"alkylating agents","score":0.5070000290870667},{"id":"https://openalex.org/keywords/microenvironment","display_name":"microenvironment","score":0.3449999988079071}],"concepts":[{"id":"https://openalex.org/C2779260929","wikidata":"https://www.wikidata.org/wiki/Q5908266","display_name":"Idelalisib","level":5,"score":0.9772443771362305},{"id":"https://openalex.org/C2781442060","wikidata":"https://www.wikidata.org/wiki/Q425745","display_name":"Bendamustine","level":4,"score":0.9720532894134521},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.8495273590087891},{"id":"https://openalex.org/C2779675984","wikidata":"https://www.wikidata.org/wiki/Q23671272","display_name":"Venetoclax","level":4,"score":0.5165461897850037},{"id":"https://openalex.org/C2779878957","wikidata":"https://www.wikidata.org/wiki/Q5984881","display_name":"Ibrutinib","level":4,"score":0.4443448483943939},{"id":"https://openalex.org/C5072461","wikidata":"https://www.wikidata.org/wiki/Q49506","display_name":"Delta","level":2,"score":0.4373489320278168},{"id":"https://openalex.org/C2778714382","wikidata":"https://www.wikidata.org/wiki/Q410656","display_name":"Ofatumumab","level":4,"score":0.4299848973751068},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.4008897542953491},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3434688448905945},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.28590789437294006},{"id":"https://openalex.org/C146978453","wikidata":"https://www.wikidata.org/wiki/Q3798668","display_name":"Aerospace engineering","level":1,"score":0.0},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"pmh:oai:digitalcommons.library.tmc.edu:utgsbs_dissertations-1626","doi":null,"is_oa":true,"landing_page_url":"https://digitalcommons.library.tmc.edu/utgsbs_dissertations/586","pdf_url":"https://digitalcommons.library.tmc.edu/utgsbs_dissertations/586","source":{"id":"https://openalex.org/S4377196655","display_name":"Digital Commons-TMC (Texas Medical Center)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1337852284","host_organization_name":"Texas Medical Center","host_organization_lineage":["https://openalex.org/I1337852284"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Dissertations & Theses (Open Access)","raw_type":"text"},{"id":"mag:1029379792","doi":null,"is_oa":false,"landing_page_url":"https://digitalcommons.library.tmc.edu/cgi/viewcontent.cgi?article=1626&context=utgsbs_dissertations","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":{"id":"pmh:oai:digitalcommons.library.tmc.edu:utgsbs_dissertations-1626","doi":null,"is_oa":true,"landing_page_url":"https://digitalcommons.library.tmc.edu/utgsbs_dissertations/586","pdf_url":"https://digitalcommons.library.tmc.edu/utgsbs_dissertations/586","source":{"id":"https://openalex.org/S4377196655","display_name":"Digital Commons-TMC (Texas Medical Center)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1337852284","host_organization_name":"Texas Medical Center","host_organization_lineage":["https://openalex.org/I1337852284"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Dissertations & Theses (Open Access)","raw_type":"text"},"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1029379792.pdf","grobid_xml":"https://content.openalex.org/works/W1029379792.grobid-xml"},"referenced_works_count":147,"referenced_works":["https://openalex.org/W78019364","https://openalex.org/W104404459","https://openalex.org/W122353466","https://openalex.org/W181491611","https://openalex.org/W221692446","https://openalex.org/W1529396499","https://openalex.org/W1560115849","https://openalex.org/W1601461124","https://openalex.org/W1658093144","https://openalex.org/W1782925843","https://openalex.org/W1964617786","https://openalex.org/W1964719993","https://openalex.org/W1965617367","https://openalex.org/W1966116761","https://openalex.org/W1967479801","https://openalex.org/W1971344938","https://openalex.org/W1973363947","https://openalex.org/W1976127594","https://openalex.org/W1976567650","https://openalex.org/W1977701732","https://openalex.org/W1978518304","https://openalex.org/W1979816280","https://openalex.org/W1980040544","https://openalex.org/W1981231641","https://openalex.org/W1982254984","https://openalex.org/W1984547206","https://openalex.org/W1984621921","https://openalex.org/W1985558864","https://openalex.org/W1985563073","https://openalex.org/W1987821813","https://openalex.org/W1989678310","https://openalex.org/W1990924960","https://openalex.org/W1991249033","https://openalex.org/W1991276398","https://openalex.org/W1992089991","https://openalex.org/W1992572858","https://openalex.org/W1993986769","https://openalex.org/W2000856801","https://openalex.org/W2001850157","https://openalex.org/W2003842525","https://openalex.org/W2004125597","https://openalex.org/W2004355167","https://openalex.org/W2005289326","https://openalex.org/W2006771504","https://openalex.org/W2008376982","https://openalex.org/W2008417818","https://openalex.org/W2008597649","https://openalex.org/W2009009231","https://openalex.org/W2009174142","https://openalex.org/W2009486785","https://openalex.org/W2010336934","https://openalex.org/W2012228539","https://openalex.org/W2014031706","https://openalex.org/W2016548691","https://openalex.org/W2017190378","https://openalex.org/W2017214208","https://openalex.org/W2019405732","https://openalex.org/W2024676945","https://openalex.org/W2025234369","https://openalex.org/W2025786205","https://openalex.org/W2027971058","https://openalex.org/W2028044172","https://openalex.org/W2028703351","https://openalex.org/W2032388082","https://openalex.org/W2034611537","https://openalex.org/W2034691869","https://openalex.org/W2036274324","https://openalex.org/W2036758696","https://openalex.org/W2038053631","https://openalex.org/W2038067635","https://openalex.org/W2038322120","https://openalex.org/W2041230280","https://openalex.org/W2042319759","https://openalex.org/W2042499074","https://openalex.org/W2045608879","https://openalex.org/W2050064417","https://openalex.org/W2050981751","https://openalex.org/W2061245152","https://openalex.org/W2062133747","https://openalex.org/W2062547838","https://openalex.org/W2063362926","https://openalex.org/W2064937772","https://openalex.org/W2069326426","https://openalex.org/W2070748566","https://openalex.org/W2072252062","https://openalex.org/W2076542620","https://openalex.org/W2078177852","https://openalex.org/W2080877772","https://openalex.org/W2083717129","https://openalex.org/W2085559300","https://openalex.org/W2086858152","https://openalex.org/W2088418102","https://openalex.org/W2089762402","https://openalex.org/W2090970397","https://openalex.org/W2092480028","https://openalex.org/W2092875419","https://openalex.org/W2096439168","https://openalex.org/W2100752860","https://openalex.org/W2101252134","https://openalex.org/W2102900988","https://openalex.org/W2109375301","https://openalex.org/W2110817748","https://openalex.org/W2111772438","https://openalex.org/W2111871531","https://openalex.org/W2116396726","https://openalex.org/W2116879609","https://openalex.org/W2117988802","https://openalex.org/W2118203690","https://openalex.org/W2120806256","https://openalex.org/W2120921507","https://openalex.org/W2121396722","https://openalex.org/W2123122199","https://openalex.org/W2123666692","https://openalex.org/W2128947691","https://openalex.org/W2129061111","https://openalex.org/W2129172946","https://openalex.org/W2129476862","https://openalex.org/W2132276725","https://openalex.org/W2135080095","https://openalex.org/W2138255741","https://openalex.org/W2139877052","https://openalex.org/W2140192991","https://openalex.org/W2140229412","https://openalex.org/W2142019712","https://openalex.org/W2145133645","https://openalex.org/W2145424727","https://openalex.org/W2145497092","https://openalex.org/W2147318282","https://openalex.org/W2147321863","https://openalex.org/W2147696493","https://openalex.org/W2152876030","https://openalex.org/W2161545183","https://openalex.org/W2162445214","https://openalex.org/W2163011434","https://openalex.org/W2163034757","https://openalex.org/W2163348695","https://openalex.org/W2163577434","https://openalex.org/W2164139183","https://openalex.org/W2166467949","https://openalex.org/W2166470267","https://openalex.org/W2167197826","https://openalex.org/W2326175431","https://openalex.org/W2332085249","https://openalex.org/W2333408219","https://openalex.org/W2340836552","https://openalex.org/W2341848374","https://openalex.org/W2397241885"],"related_works":["https://openalex.org/W2005952346","https://openalex.org/W2980122808","https://openalex.org/W2301884883","https://openalex.org/W4220665168","https://openalex.org/W4211190604","https://openalex.org/W2527918791","https://openalex.org/W1974396489","https://openalex.org/W2552025694","https://openalex.org/W13715430","https://openalex.org/W2555601066"],"abstract_inverted_index":{"Class":[0],"I":[1],"phosphatidylinositol":[2],"3-kinase":[3],"isoforms":[4],"(\u03b1,":[5],"\u03b2,":[6],"\u03b4,":[7],"and":[8,18,22,35,44,50,69,79,88,90,125,147,163,206,212,221,236,263,278,303,324,327],"\u03b3)":[9],"play":[10],"a":[11,73,82,103,193,199,207,231,241,270,344],"major":[12],"role":[13,84,335],"in":[14,32,47,51,76,85,95,113,181,202,209,254,292,307,330,339],"cancer":[15],"cell":[16,295],"growth":[17],"survival.":[19,70],"PI3K":[20,27,37,71,134,337],"\u03b1":[21,146],"\u03b2":[23,148],"are":[24],"most":[25],"studied.":[26],"pathway":[28,78],"is":[29,39,58,72,93,102,240],"highly":[30],"dysregulated":[31],"many":[33,96],"cancers":[34],"aberrant":[36],"signaling":[38,64,195],"associated":[40],"with":[41,186,215,341],"oncogene":[42],"mutations":[43],"disease":[45],"progression":[46],"solid":[48],"tumors":[49],"hematologic":[52],"malignancies.":[53],"Chronic":[54],"lymphocytic":[55],"leukemia":[56],"(CLL)":[57],"driven":[59],"by":[60,115],"B-cell":[61,67,86,97],"receptor":[62],"(BCR)":[63],"that":[65,141,227,251,301,313],"promotes":[66,111],"proliferation":[68],"critical":[74],"node":[75],"BCR":[77,121],"PI3K\u03b4":[80,108,152],"has":[81],"pivotal":[83],"development":[87],"maintenance":[89],"this":[91,264],"isoform":[92],"over-expressed":[94],"malignancies,":[98],"including":[99],"CLL.":[100,331],"Idelalisib":[101,110,174,184],"FDA":[104,242],"approved":[105,243],"small":[106],"molecule":[107],"inhibitor.":[109],"apoptosis":[112,169,180],"CLL":[114,172,182,247,294,348],"disrupting":[116],"molecular":[117],"pathways":[118],"related":[119],"to":[120,143,167,218,269,318],"signaling,":[122,135],"leukemic":[123],"migration":[124],"signals":[126],"from":[127],"the":[128,314,333],"microenvironment.":[129],"Importantly,":[130],"idelalisib":[131,228,279,302],"inhibits":[132],"BCR-derived":[133],"dampening":[136],"survival":[137],"signals.":[138],"We":[139,197,249],"hypothesized":[140,250],"similar":[142],"inhibition":[144],"of":[145,151,170,179,191,286,320,336],"isoforms,":[149],"attenuation":[150],"will":[153,259,267],"repress":[154],"transcription,":[155],"reduce":[156],"short-lived":[157],"anti-apoptotic":[158],"proteins,":[159],"induce":[160],"DNA":[161,234,257,325],"damage":[162,235,258,326],"repair":[164,237,328],"responses,":[165],"leading":[166],"enhanced":[168,293],"malignant":[171],"cells.":[173],"treatment":[175,185,290],"induced":[176,229,283],"moderate":[177,284],"levels":[178,323],"lymphocytes.":[183],"IgM":[187],"stimulation":[188],"decreased":[189],"phosphorylation":[190],"AKT,":[192],"downstream":[194],"molecule.":[196],"observed":[198,226],"significant":[200],"decrease":[201],"global":[203],"RNA":[204],"synthesis":[205],"decline":[208,253],"Mcl-1":[210,321],"transcript":[211],"protein":[213,220,322],"levels,":[214],"no":[216],"changes":[217],"Bcl-2":[219],"mRNA":[222],"expression.":[223],"Interestingly,":[224],"we":[225],"\u03b3H2AX,":[230],"hallmark":[232],"for":[233,246,347],"response.":[238],"Bendamustine":[239],"alkylating":[244],"agent":[245],"therapy.":[248,349],"idelalisib-mediated":[252],"Mcl-1and":[255],"bendamustine-induced":[256],"sensitize":[260],"B-CLL":[261],"cells":[262],"mechanism-based":[265],"combination":[266,289,340],"lead":[268],"synergistic":[271,308],"interaction.":[272],"At":[273],"clinically":[274],"relevant":[275],"concentrations,":[276],"bendamustine":[277,304,342],"as":[280],"single":[281],"agents":[282],"level":[285],"apoptosis;":[287],"however,":[288],"resulted":[291,306],"death.":[296],"Combination":[297],"index":[298],"assessment":[299],"demonstrated":[300],"couplet":[305],"cytotoxicity.":[309],"Mechanistic":[310],"investigations":[311],"suggest":[312],"synergy":[315],"maybe":[316],"due":[317],"modulation":[319],"responses":[329],"Collectively,":[332],"emerging":[334],"inhibitor":[338],"provides":[343],"unique":[345],"modality":[346]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}